198 related articles for article (PubMed ID: 2336835)
1. The metabolic fate of 14C-ximoprofen in rats, baboons and humans.
Mayo BC; Chasseaud LF; Hawkins DR; Taylor IW; Legeai J
Xenobiotica; 1990 Mar; 20(3):233-46. PubMed ID: 2336835
[TBL] [Abstract][Full Text] [Related]
2. Metabolic fate of the thrombolytic agent benzarone in man: comparison with the rat and dog.
Wood SG; John BA; Chasseaud LF; Bonn R; Grote H; Sandrock K; Darragh A; Lambe RF
Xenobiotica; 1987 Jul; 17(7):881-96. PubMed ID: 3660858
[TBL] [Abstract][Full Text] [Related]
3. Disposition of a new nonsteroidal anti-inflammatory agent, S-2-[4-(3-methyl-2-thienyl)phenyl]propionic acid, in rats, dogs and monkeys.
Konishi T; Okada S; Nishikawa H; Esumi Y; Kitamura S; Tatsumi K
Arzneimittelforschung; 1998 Mar; 48(3):266-74. PubMed ID: 9553685
[TBL] [Abstract][Full Text] [Related]
4. The disposition of radioactivity after administration of the anthelminthic methyl-14C-5-cyclopropylcarbonyl-2-benzimidazole carbamate (ciclobendazole) to rats and dogs.
Brodie RR; Mayo BC; Chasseaud LF; Hawkins DR
Arzneimittelforschung; 1977; 27(3):593-8. PubMed ID: 577426
[TBL] [Abstract][Full Text] [Related]
5. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of 4-acetylaminophenylacetic acid. 1st communication: absorption, distribution, metabolism and excretion in mice, rats, dogs and monkeys after single administration of 14C-labeled compound.
Sugihara K; Morino A; Nomura A; Iida S; Sugiyama M
Arzneimittelforschung; 1990 Jul; 40(7):800-5. PubMed ID: 2222556
[TBL] [Abstract][Full Text] [Related]
7. Orally active inhibitors of human leukocyte elastase. I. Disposition of L-683,845 in rats and rhesus monkeys.
Vincent SH; Painter SK; Krieter PA; Colletti AE; Lyszack E; Rosegay A; Dean D; Luffer-Atlas D; Miller RR; Cioffe C; Chiu SH
Drug Metab Dispos; 1996 Dec; 24(12):1369-77. PubMed ID: 8971144
[TBL] [Abstract][Full Text] [Related]
8. The fate of saccharin impurities: the excretion and metabolism of [3-14C]Benz[d]-isothiazoline-1,1-dioxide (BIT) in man and rat.
Renwick AG; Williams RT
Xenobiotica; 1978 Aug; 8(8):475-86. PubMed ID: 695691
[TBL] [Abstract][Full Text] [Related]
9. Absorption, distribution, metabolism and excretion of [14C]ebastine after a single administration in rats.
Fujii T; Matsumoto S; Amejima H; Hatoyama T; Nakao M; Kagemoto A; Tanaka K; Miyazaki H
Arzneimittelforschung; 1994 Apr; 44(4):527-38. PubMed ID: 7912071
[TBL] [Abstract][Full Text] [Related]
10. Pre-clinical pharmacokinetics of the cyclooxygenase-inhibiting nitric oxide donor (CINOD) AZD3582.
Fagerholm U; Breuer O; Swedmark S; Hoogstraate J
J Pharm Pharmacol; 2005 May; 57(5):587-97. PubMed ID: 15901348
[TBL] [Abstract][Full Text] [Related]
11. Antilipidemic drugs. Part 4: The metabolic fate of the hypolipidemic agent isopropyl-[4'-(p-chlorobenzoyl)-2-phenoxy-2-methyl]-protionate (LF 178) in rats, dog and man.
Brodie RR; Chasseaud LF; Elson FF; Franklin ER; Taylor T
Arzneimittelforschung; 1976; 26(5):896-901. PubMed ID: 989365
[TBL] [Abstract][Full Text] [Related]
12. The metabolic fate of the coronary vasodilator 4-(3,4,5-Trimethoxycinnamoyl)-1-(N-pyrrolidinocarbonylmethyl)piperazine (cinepazide) in the rat, dog and man.
Cameron BD; Chasseaud LF; Hawkins DR; Taylor T
Xenobiotica; 1976 Jul; 6(7):441-55. PubMed ID: 997590
[TBL] [Abstract][Full Text] [Related]
13. Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl] benzoic acid. 4th communication: absorption, metabolism, excretion and plasma protein binding in various animals and man.
Mizojiri K; Okabe H; Sugeno K; Misaki A; Ito M; Kominami G; Esumi Y; Takaichi M; Harada T; Seki H; Inaba A
Arzneimittelforschung; 1997 Mar; 47(3):259-69. PubMed ID: 9105544
[TBL] [Abstract][Full Text] [Related]
14. Excretion and metabolism of recainam, a new anti-arrhythmic drug, in laboratory animals and humans.
Scatina JA; Wells DS; Kimmel HB; Kemper CJ; Sisenwine SF
Drug Metab Dispos; 1990; 18(5):746-52. PubMed ID: 1981731
[TBL] [Abstract][Full Text] [Related]
15. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y
Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675
[TBL] [Abstract][Full Text] [Related]
16. Metabolism and pharmacokinetics of the dihydropyridine calcium antagonist, ryosidine, in man.
Midgley I; Chasseaud LF; Taylor IW; Walmsley LM; Fowkes AG; Darragh A; Lambe RF; Bonn R
Xenobiotica; 1985 Nov; 15(11):965-77. PubMed ID: 4082636
[TBL] [Abstract][Full Text] [Related]
17. The absorption, metabolism and excretion of (14C)-AR-L 115 BS in the baboon.
Cameron BD; Draffan GH; Dunsire JP; Zimmer A
Arzneimittelforschung; 1981; 31(1a):217-20. PubMed ID: 7195225
[TBL] [Abstract][Full Text] [Related]
18. Metabolic fate of the beta-blocker 14C-bupranolol in humans, dogs, and rhesus monkeys.
Waller AR; Chasseaud LF; Bonn R; Taylor T; Darragh A; Girkin R; Down WH; Doyle E
Drug Metab Dispos; 1982; 10(1):51-4. PubMed ID: 6124383
[TBL] [Abstract][Full Text] [Related]
19. The physiological disposition of the anti-tussive agent, 1,2,3,4a,9b-hexahydro-8,9b-dimethyl-4-[3-(4-methylpiperazin-1-yl)propionamido]dibenzofuran-3-one dihydrochloride Azipranone, in man, rat, dog and baboon.
Daniel JW; James GW; Rowlands DA; Taylor JB
Xenobiotica; 1978 May; 8(5):321-9. PubMed ID: 96617
[TBL] [Abstract][Full Text] [Related]
20. Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat.
Schoenig GP; Hartnagel RE; Osimitz TG; Llanso S
Drug Metab Dispos; 1996 Feb; 24(2):156-63. PubMed ID: 8742226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
